Viruses that infect and kill bacteria used to treat infections in the pre-antibiotic era a century ago may have a new role in preventing formation of the sticky biofilms of bacteria responsible for infections on implanted medical devices. That's the topic of a report in the ACS journal Biomacromolecules.
Marek Urban and colleagues explain that bacteriophages were first used to treat bacterial infections in the 19th century. These viruses more than 1,000 different kinds exist attack disease-causing bacteria. The scientists focused on use of phages to wage "microbial warfare" on the films of bacteria that form on catheters, stents and other medical implants. These infections, which often involve antibiotic-resistant bacteria, strike more than a million patients annually in the United States alone, increasing hospital bills by almost $1 billion.
They describe attachment of phages to the surfaces of materials like those used in implanted medical devices, and evidence that the phages remain active, killing E. coli and Staphylococcus aureus. Those bacteria cause the most common hospital-acquired infections. The technology can attach phages to almost any surface, and is "a promising and effective means of not only combating antibiotic-resistant infections, but also the technological platform for the development of bacteria sensing and detecting devices."
The authors acknowledge funding from the National Science Foundation; the Sirrine Foundation; and the Mississippi INBRE, which is funded by the National Institute of General Medical Sciences, National Institutes of Health.
Source: American Chemical Society
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.